# Nevirapine

NDC: 0378-4890
Generic name: nevirapine
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20141029

FDA application: ANDA205651

## Active ingredients

- NEVIRAPINE: 400 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-4890"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-4890
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=690da74b-2481-47fc-93ae-8340e0caf0a4